Literature DB >> 31501540

Epstein-Barr virus ncRNA from a nasopharyngeal carcinoma induces an inflammatory response that promotes virus production.

Zhe Li1,2, Ming-Han Tsai1,2,3, Anatoliy Shumilov1,2, Francesco Baccianti1,2, Sai Wah Tsao4, Remy Poirey1,2, Henri-Jacques Delecluse5,6.   

Abstract

The Epstein-Barr virus M81 strain, isolated from a nasopharyngeal carcinoma, induces potent spontaneous virus production in infected B cells. We found that the M81 non-coding Epstein-Barr-encoded RNA EBER2, which carries polymorphisms that are mainly restricted to viruses found in endemic nasopharyngeal carcinomas, markedly stimulated this process. M81 EBER2 increased CXCL8 expression, and this chemokine enhanced spontaneous lytic replication levels in M81-infected B cells. Both events resulted from the endocytosis of extracellular vesicles containing EBER2 that were generated by neighbouring M81-infected B cells, thereby generating a paracrine loop. These effects were strictly dependent on a functional Toll-like receptor 7 (TLR7), a sensor of single-stranded RNA located in the endosome of these cells. These unique properties of M81 EBER2 could be ascribed to its unusually high expression level and to the ability of its single-stranded region to activate TLR7; both of these properties were dependent on M81-specific polymorphisms. Thus, M81 induced chronic inflammation in its target cells and this resulted in increased virus production. These observations provide a mechanistic molecular link between M81 virus replication-a central viral function and a cancer risk factor-and the production of a chemokine involved in inflammation and carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31501540     DOI: 10.1038/s41564-019-0546-y

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


  48 in total

1.  High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.

Authors:  Kwai Fung Hui; Tsz Fung Chan; Wanling Yang; Jiangshan Jane Shen; Ki Pui Lam; Hin Kwok; Pak C Sham; Sai Wah Tsao; Dora L Kwong; Maria Li Lung; Alan Kwok Shing Chiang
Journal:  Int J Cancer       Date:  2019-01-07       Impact factor: 7.396

2.  Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas.

Authors:  Ming-Han Tsai; Ana Raykova; Olaf Klinke; Katharina Bernhardt; Kathrin Gärtner; Carol S Leung; Karsten Geletneky; Serkan Sertel; Christian Münz; Regina Feederle; Henri-Jacques Delecluse
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

Review 3.  Genetics of Epstein-Barr virus microRNAs.

Authors:  Olaf Klinke; Regina Feederle; Henri-Jacques Delecluse
Journal:  Semin Cancer Biol       Date:  2014-03-03       Impact factor: 15.707

4.  Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata.

Authors:  J Komano; S Maruo; K Kurozumi; T Oda; K Takada
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

Review 5.  Epstein-Barr virus: more than 50 years old and still providing surprises.

Authors:  Lawrence S Young; Lee Fah Yap; Paul G Murray
Journal:  Nat Rev Cancer       Date:  2016-09-30       Impact factor: 60.716

6.  Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus.

Authors:  M R Lerner; N C Andrews; G Miller; J A Steitz
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

7.  Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection.

Authors:  Anne L Palser; Nicholas E Grayson; Robert E White; Craig Corton; Samantha Correia; Mohammed M Ba Abdullah; Simon J Watson; Matthew Cotten; John R Arrand; Paul G Murray; Martin J Allday; Alan B Rickinson; Lawrence S Young; Paul J Farrell; Paul Kellam
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

8.  High prevalence of the EBER variant EB-8m in endemic nasopharyngeal carcinomas.

Authors:  Zhi-chao Shen; Bing Luo; Jian-ning Chen; Yan Chao; Chun-kui Shao; Qian-qian Liu; Yun Wang
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

9.  Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases.

Authors:  Samantha Correia; Ray Bridges; Fanny Wegner; Cristina Venturini; Anne Palser; Jaap M Middeldorp; Jeffrey I Cohen; Mario A Lorenzetti; Irene Bassano; Robert E White; Paul Kellam; Judith Breuer; Paul J Farrell
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

10.  Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.

Authors:  Samantha Correia; Anne Palser; Claudio Elgueta Karstegl; Jaap M Middeldorp; Octavia Ramayanti; Jeffrey I Cohen; Allan Hildesheim; Maria Dolores Fellner; Joelle Wiels; Robert E White; Paul Kellam; Paul J Farrell
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

View more
  15 in total

Review 1.  Long non-coding RNAs in nasopharyngeal carcinoma: biological functions and clinical applications.

Authors:  Yao Tang; Xiusheng He
Journal:  Mol Cell Biochem       Date:  2021-05-17       Impact factor: 3.396

2.  The Epstein-Barr virus noncoding RNA EBER2 transactivates the UCHL1 deubiquitinase to accelerate cell growth.

Authors:  Zhe Li; Francesco Baccianti; Susanne Delecluse; Ming-Han Tsai; Anatoliy Shumilov; Xianliang Cheng; Sicong Ma; Ingrid Hoffmann; Remy Poirey; Henri-Jacques Delecluse
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-26       Impact factor: 11.205

Review 3.  Epstein-Barr virus: Biology and clinical disease.

Authors:  Blossom Damania; Shannon C Kenney; Nancy Raab-Traub
Journal:  Cell       Date:  2022-09-15       Impact factor: 66.850

4.  The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.

Authors:  Weiyue Ding; Chong Wang; Yohei Narita; Hongbo Wang; Merrin Man Long Leong; Alvin Huang; Yifei Liao; Xuefeng Liu; Yusuke Okuno; Hiroshi Kimura; Benjamin Gewurz; Mingxian Teng; Shuilin Jin; Yoshitaka Sato; Bo Zhao
Journal:  J Virol       Date:  2022-09-12       Impact factor: 6.549

5.  A Polymorphism in the Epstein-Barr Virus EBER2 Noncoding RNA Drives In Vivo Expansion of Latently Infected B Cells.

Authors:  Yiping Wang; Nathan Ungerleider; Brett A Hoffman; Mehmet Kara; Paul J Farrell; Erik K Flemington; Nara Lee; Scott A Tibbetts
Journal:  mBio       Date:  2022-06-01       Impact factor: 7.786

Review 6.  Viral non-coding RNAs: Stealth strategies in the tug-of-war between humans and herpesviruses.

Authors:  Takanobu Tagawa; Anna Serquiña; Insun Kook; Joseph Ziegelbauer
Journal:  Semin Cell Dev Biol       Date:  2020-07-03       Impact factor: 7.727

Review 7.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

Review 8.  Extracellular Vesicles in Viral Spread and Antiviral Response.

Authors:  Raquel Bello-Morales; Inés Ripa; José Antonio López-Guerrero
Journal:  Viruses       Date:  2020-06-08       Impact factor: 5.048

9.  B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.

Authors:  James C Romero-Masters; Shane M Huebner; Makoto Ohashi; Jillian A Bristol; Bayleigh E Benner; Elizabeth A Barlow; Gail L Turk; Scott E Nelson; Dana C Baiu; Nicholas Van Sciver; Erik A Ranheim; Jenny Gumperz; Nathan M Sherer; Paul J Farrell; Eric C Johannsen; Shannon C Kenney
Journal:  PLoS Pathog       Date:  2020-02-14       Impact factor: 6.823

10.  Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.

Authors:  Benjamin Fournier; David Boutboul; Julie Bruneau; Charline Miot; Cécile Boulanger; Marion Malphettes; Isabelle Pellier; Bertrand Dunogué; Benjamin Terrier; Felipe Suarez; Stéphane Blanche; Martin Castelle; Sarah Winter; Henri-Jacques Delecluse; Thierry Molina; Capucine Picard; Stephan Ehl; Despina Moshous; Lionel Galicier; Vincent Barlogis; Alain Fischer; Bénédicte Neven; Sylvain Latour
Journal:  J Exp Med       Date:  2020-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.